Attorney General Jeff Sessions is back in the news as he makes threats against legalized marijuana.
Sessions won’t disclose what his plans are, but he has indicated his strong opposition to any form of legalization, medicinal or otherwise.
This news came on the heels of a statement from President Trump addressing the opioid crisis sweeping the country.
Sessions’ comments were wreathed in a smoke screen of scare tactics and outright misinformation. Despite a growing mountain of evidence showing that marijuana actually reduces opioid use in states where it is legal, Sessions chose instead to cite outdated reefer madness hyperbole such as, “It’s a gateway drug”, and the old tried and true fear mongering of, “What about the children?”
Meanwhile, states like Colorado have seen a 25% reduction in opioid use since legalizing marijuana and, equally significant, a drop in teen use of marijuana.
As far as the children are concerned, apparently Mr. Sessions has never witnessed the dramatic results of cannabis in treating seizure disorders in children. I guess he doesn’t care about those children.
The evidence being accumulated since the legalization of medicinal and recreational cannabis in over half the States in the U.S. is impossible to ignore.
Unless you’re a 70 year old Attorney General who places personal feelings over actual justice, or a grotesquely overweight Chris Christie.
The Governor of New Jersey is Chairman of the White House’s Commission on Combating Drug Addiction and the Opioid Crisis.
Governor Christie last week called upon the President to reject any efforts to acknowledge marijuana’s promising role in mitigating opioid abuse and dependency, and ignoring peer reviewed studies showing marijuana has efficacy in combating opioid addiction.
The commission released the following statement:
“The Commission acknowledges that there is an active movement to promote the use of marijuana as an alternative medication for chronic pain and as a treatment for opioid addiction. … There is a lack of sophisticated outcome data on dose, potency, and abuse potential for marijuana. This mirrors the lack of data in the 1990’s and early 2000’s when opioid prescribing multiplied across health care settings and led to the current epidemic of abuse, misuse and addiction. The Commission urges that the same mistake is not made with the uninformed rush to put another drug legally on the market in the midst of an overdose epidemic.”
“K” is a paramedic in the city of Pittsburgh. Because of the nature of her work, she asked we don’t use her real name.
“K” has 10 years of experience and has never encountered a single instance of a marijuana overdose. Her biggest concern is marijuana being laced with other drugs.
“We sometimes see marijuana laced with embalming fluid or PCP” said K. “Often the person smoking doesn’t know what they’re being given.”
The fact that 29 States have legalized some form of medicinal cannabis means there is a wealth of evidence being accumulated showing the efficacy of medicinal cannabis. Instances like “K” talked about shows the need for regulation, so consumers don’t end up with tainted marijuana.
Ironically, it is the commission itself using outdated information to support an untenable position in the light of the many peer reviewed studies that are currently available.
NORML has assembled a list of studies here:
We urge President Trump to reject the advice of his commission and allow States and the medical community to continue providing this valuable medicine to patients who need it.
As of last week, a new poll shows a record number of Americans now favor legalization of marijuana (62%) and it’s no wonder the public is coming around. In States where it’s legal, business is booming, bringing those States desperately needed revenue, much of which ironically goes to fight and treat opioid abuse.
President Trump is pro business and anti-crime. Marijuana legalization addresses both those concerns while providing medicine to people who need it.
Perhaps the President’s commission chair, Governor Christie, should check out the U.S. patent office, where tucked away in a file is a patent on THC for treatment of cancer and brain trauma.
The patent is owned by the United States of America.